Mahmoud R Jaafari Selected Research

Mahmoud R Jaafari Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 10/2008
8	Leishmaniasis 01/2017 - 08/2007
4	Atherosclerosis 01/2022 - 10/2018
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2016
3	Carcinoma (Carcinomatosis) 01/2020 - 04/2013
3	Dehydration (Water Stress) 05/2009 - 08/2007
2	Dyslipidemias (Dyslipidemia) 01/2022 - 10/2018
2	Inflammation (Inflammations) 07/2021 - 01/2017
2	Infections 06/2009 - 08/2007
1	Atherosclerotic Plaque (Atheroma) 10/2021
1	Hypercholesterolemia 10/2021
1	Enterobiasis 01/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Osteoarthritis 01/2020
1	Knee Osteoarthritis 01/2020
1	Pain (Aches) 01/2020
1	Multiple Myeloma 01/2020
1	Parasitic Diseases (Parasitic Disease) 01/2019
1	Cutaneous Leishmaniasis 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Endophthalmitis (Ophthalmia) 05/2009
1	Retinal Detachment (Retinal Detachments) 05/2009
1	Vitreous Hemorrhage 05/2009
1	Cataract (Cataracts) 05/2009

Drug/Important Bio-Agent (IBA)

15	Liposomes (Liposome)IBA 01/2022 - 08/2007
4	VaccinesIBA 07/2021 - 04/2008
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
4	CPG-oligonucleotideIBA 10/2011 - 08/2007
3	AntigensIBA 12/2012 - 08/2007
2	AntibodiesIBA 07/2021 - 02/2020
2	Peptides (Polypeptides)IBA 02/2020 - 01/2018
2	Bortezomib (Velcade)FDA Link 01/2020 - 01/2020
2	Proteasome InhibitorsIBA 01/2020 - 01/2020
2	Niclosamide FDA Link 01/2020 - 01/2019
2	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 10/2008
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019 - 10/2008
2	Phospholipids (Phosphatides)FDA LinkGeneric 10/2018 - 11/2009
1	Dimyristoylphosphatidylcholine (DMPC)IBA 01/2022
1	dimyristoylphosphatidylglycerol (DMPG)IBA 01/2022
1	distearoyl phosphatidylglycerol (DSPG)IBA 01/2022
1	LipidsIBA 10/2021
1	PhosphatidylserinesIBA 10/2021
1	aluminum sulfate (alum)IBA 07/2021
1	Therapeutic UsesIBA 07/2021
1	pyrvinium (Vankin)FDA Link 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Nanoparticle Drug Delivery SystemIBA 01/2020
1	CurcuminIBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	Scarlet Red (Sudan IV)IBA 10/2018
1	CollagenIBA 10/2018
1	Lipid Bilayers (Lipid Bilayer)IBA 10/2018
1	LDL Receptors (LDL Receptor)IBA 10/2018
1	CholesterolIBA 10/2018
1	LigandsIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	liposomal amphotericin B FDA Link 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2017
1	1,2- distigmasterylhemisuccinoyl- glycero- 3- phosphocholineIBA 01/2017
1	ChemokinesIBA 01/2016
1	pigment epithelium-derived factorIBA 01/2016
1	Cytosine DeaminaseIBA 01/2016
1	InterferonsIBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 12/2015
1	Polyethylene (Polythene)IBA 04/2013
1	BuffersIBA 04/2013
1	crocinIBA 04/2013
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 12/2012
1	AlginatesIBA 10/2011
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 06/2009
1	Bevacizumab (Avastin)FDA Link 05/2009
1	OligodeoxyribonucleotidesIBA 04/2008
1	Leishmania major stress-inducible protein 1IBA 04/2008

Therapy/Procedure

4	Therapeutics 02/2020 - 01/2016
3	Fluid Therapy (Oral Rehydration Therapy) 05/2009 - 08/2007
1	Immunotherapy 02/2020
1	Drug Therapy (Chemotherapy) 02/2020
1	Microspheres (Microsphere) 10/2011
1	Nanospheres 05/2011
1	Injections 05/2009
1	Intravitreal Injections 05/2009